36 completed. 36 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 36 | Completed 36 |
Follow Nephritis: new trials by email Literature Review of Nephritis trials Research Report on Nephritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Albuminuria Lowering Effect of Dapagliflozin, Spironolactone and Their Combination in Adult Patients With Alport Syndrome (COMBINE-ALPORT) Treatment with Spironolactone followed by Dapagliflozin followed by their combination, Treatment with Dapagliflozin followed by Spironolactone followed by their combination - Alport Syndrome, Thin Basement Membrane Disease | Phase 4 | Completed | Stefan Lujinschi | 12 | 2024-02-26 | 2026-06-25 |
| SGLT2 Inhibitors Between Reno Protective Effects and Impact on Bone and Mineral Disease Among Lupus Nephritis Patients Dapagliflozin tablet, placebo - SGLT2 INHIBITORS, Lupus Nephritis | Phase 4 | Completed | Mansoura University | 100 | 2022-10-08 | 2024-10-15 |
| Cardio Renal Effects of SGLT2 Inhibitors Among Lupus Nephritis Patients dapagliflozin, placebo - SLE, Lupus Nephritis | Phase 4 | Completed | Mansoura University | 84 | 2022-10-01 | 2025-04-16 |
| Comparison between2 Drugs in Lupus Nephritis cyclo phosphamide, mycophenolate - Lupus Nephritis | Phase 4 | Completed | Al-Azhar University | 40 | 2021-04-05 | 2022-06-21 |
| Rituximab and RASi in Patients with IgAN Rituximab, RAS 2410 - IgA Nephropathy | Phase 4 | Completed | Nan Chen,MD | 116 | 2020-07-01 | 2025-03-14 |
| Efficacy of Lower Dose Prednisolone in the Induction of Remission of Lupus Nephritis Prednisolone - Lupus Nephritis | Phase 4 | Completed | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 32 | 2018-07-16 | 2019-10-31 |
| Adrenocorticotropic Hormone in Membranous Nephropathy ACTHar - Membranous Nephropathy | Phase 4 | Completed | Icahn School of Medicine at Mount Sinai | 5 | 2018-03-19 | 2022-08-15 |
| Treating Pyelonephritis an Urosepsis With Pivmecillinam pivmecillinam - Pyelonephritis, Urinary Tract Infections | Phase 4 | Completed | Sykehuset i Vestfold HF | 53 | 2017-09-29 | 2020-04-22 |
| Management of Sub-Clinical Bacteriuria in Pregnancy Antibiotic, Standard Prenatal Care - Cystitis, Cystitis;Puerperium | Phase 4 | Completed | The University of Texas Health Science Center, Houston | 60 | 2017-09-15 | 2020-04-03 |
| Comparison of Low Dose Versus High Dose Cyclophosphamide as Induction Therapy in the Treatment of Lupus Nephritis Cyclophosphamide, Azathioprine, Methylprednisolone - Lupus Nephritis | Phase 4 | Completed | Jawaharlal Institute of Postgraduate Medical Education & Research | 75 | 2015-12-01 | 2017-03-06 |
| Treating to Reduce Albuminuria and Normalize Hemodynamic Function in Focal ScLerosis With dApagliflozin Trial Effects Dapagliflozin - Focal Segmental Glomerulosclerosis | Phase 4 | Completed | University Health Network, Toronto | 10 | 2015-09-01 | 2018-01-16 |
| Pharmacokinetics of Ciprofloxacin in Pediatric Patients ciprofloxacin - Urinary Tract Infection, Pyelonephritis | Phase 4 | Completed | University Hospital, Ghent | 22 | 2015-04-01 | 2023-09-05 |
| Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy: a Self- Controlled Study Hydroxychloroquine Sulfate - Primary IgA Nephropathy | Phase 4 | Completed | LLiu | 20 | 2015-01-01 | 2015-12-17 |
| Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication Patient Information Leaflet (PIL) - Ankle Sprain, Infectious Colitis | Phase 4 | Completed | Floralis | 211 | 2014-09-01 | 2015-08-27 |
| A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome Tacrolimus, Prednisolone - MCNS, Minimal Change Nephrotic Syndrome (MCNS) | Phase 4 | Completed | Astellas Pharma Korea, Inc. | 144 | 2012-07-16 | 2024-10-31 |
| Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients Repository Corticotropin Injection, Placebo - Proteinuria, Idiopathic Membranous Nephropathy | Phase 4 | Completed | Mallinckrodt | 60 | 2011-08-01 | 2019-11-20 |
| Long-Acting Tacrolimus for the Treatment of Resistant Lupus Nephritis Long-acting tacrolimus (Advagraf, Astellas Pharma) - Lupus Nephritis | Phase 4 | Completed | Chinese University of Hong Kong | 2 | 2010-09-01 | 2012-12-04 |
| Low-dose Combination of Mycophenolate Mofetil (MMF) and Tacrolimus (Tac) for Refractory Lupus Nephritis low dose combination of MMF and Tac - Lupus Nephritis | Phase 4 | Completed | Tuen Mun Hospital | 20 | 2010-08-01 | 2014-03-04 |
| Pilot Study of Velcade® in IgA Nephropathy Bortezomib (Velcade®) - Chronic Kidney Disease, IgA Nephropathy | Phase 4 | Completed | The Rogosin Institute | 11 | 2010-07-01 | 2018-11-16 |
| Prospective Study Evaluating the Effect of Repository Corticotropin in the Treatment of Various Nephrotic Syndromes Repository corticotrophin - Nephrotic Syndromes | Phase 4 | Completed | Arizona Kidney Disease and Hypertension Center | 18 | 2009-12-01 | 2011-07-14 |
Showing 20 of 36. Sign in to see all of them.
Proteinuria (14) · Glomerulonephritis, IGA (12) · Glomerulonephritis (9) · Lupus Nephritis (9) · Pyelonephritis (6) · Glomerulonephritis, Membranous (5) · Nephrotic Syndrome (5) · Renal Insufficiency, Chronic (4) · Lupus Erythematosus, Systemic (3) · Glomerulosclerosis, Focal Segmental (2) · Kidney Diseases (2) · Nephrosis, Lipoid (2) · Urinary Tract Infections (2) · Albuminuria (1)
Female Urogenital Diseases (36) · Female Urogenital Diseases and Pregnancy Complications (36) · Male Urogenital Diseases (36) · Urogenital Diseases (36) · Urologic Diseases (36) · Kidney Diseases (34) · Immune System Diseases (26) · Autoimmune Diseases (25) · Glomerulonephritis (19) · Pathological Conditions, Signs and Symptoms (15) · Signs and Symptoms (15) · Urination Disorders (15) · Urological Manifestations (15) · Skin and Connective Tissue Diseases (11)
Mycophenolic Acid (5) · Tacrolimus (5) · Prednisolone (3) · dapagliflozin (3) · Adrenocorticotropic Hormone (2) · Anti-Bacterial Agents (2) · Azathioprine (2) · Rituximab (2) · Steroids (2) · Adenosine Triphosphate (1) · Amdinocillin Pivoxil (1) · Bortezomib (1) · Calcitriol (1) · Ciprofloxacin (1) · Cyclophosphamide (1)
Chinese University of Hong Kong (3) · Mansoura University (2) · The University of Hong Kong (2) · Tuen Mun Hospital (2) · A. Manzoni Hospital (1) · Al-Azhar University (1) · Arizona Kidney Disease and Hypertension Center (1) · Assistance Publique - Hôpitaux de Paris (1) · Astellas Pharma Korea, Inc. (1) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1) · Columbia University (1) · Floralis (1) · Guangdong Provincial People's Hospital (1) · Hospital Britanico (1) · IRCCS Burlo Garofolo (1)
China (8) · United States (7) · Egypt (3) · Hong Kong (3) · Italy (3) · Canada (2) · France (2) · Argentina (1) · Bangladesh (1) · Belgium (1) · Chile (1) · Finland (1) · India (1) · Mexico (1) · Norway (1)
Cheuk-Chun Szeto, MD (2) · Akwugo A Eziefule, MD (1) · Antonello Pani, MD (1) · CC Mok, MD, FRCP (1) · Choli Hartono, MD (1) · Claudio Ponticelli, MD (1) · Claudio Pozzi, MD (1) · Dr. Sonal Mehra, MD (1) · Dr. Vir Singh Negi, DM (1) · Fernando C. Fervenza, M.D. (1)
PMID 34778952, PMID 26032537, PMID 29450636, PMID 38299639, PMID 11511139, PMID 12209517, PMID 1356175, PMID 16014059, PMID 18436082, PMID 18490378, PMID 19369404, PMID 21626222, PMID 21680850, PMID 22075320, PMID 22291112, PMID 22722778, PMID 24009220, PMID 24191893, PMID 24641955, PMID 25550339, PMID 27821627, PMID 29515299, PMID 29987142, PMID 29988921, PMID 30787085, PMID 31492152, PMID 32448782, PMID 3511372, PMID 35230699, PMID 35590284, PMID 36853224, PMID 42549085, PMID 8815753
2008 (1), 2014 (1), 2016 (1)